Browse 59 market data tables and 63 figures spread through 223 pages and in-depth TOC on “Cold Pain Therapy Market by Product (OTC (Pharmaceuticals - Gel, Cream, Patch, Spray) (Medical Devices - Wraps, Ice Pack), Prescription (Non-Motorized Devices)), Application (Musculoskeletal Disorders, Sport Medicine, Physical Therapy) - Forecast to 2021”
Early buyers will receive 10% customization on reports.
This report studies the global cold pain therapy market over the forecast period of 2016 to 2021. The market is expected to reach USD 1.08 Billion by 2021, at CAGR of 5.0% from 2016 to 2021. A number of factors such as aggressive marketing and promotion activities by major players, active participation of people in sports and other outdoor activities, easy availability of cold packs from a variety of Chinese manufacturers, growing aging population and arthritis incidences, and clinical evidence in favor of menthol-based topical analgesics are driving the growth of the global cold pain therapy market. On the other hand, factors such as the availability of alternative non-drug/device pain management therapies, stringent regulations on ammonium nitrate usage, and the high usage of low-priced analgesic pills to obtain immediate relief pose challenges to market players.
The report covers two major product types OTC and prescription-based cold pain therapy products. OTC products are further segmented into pharmaceuticals (gels, ointments, creams, sprays, foams, patches, and roll-ons) and medical devices (cold packs and cooling towels, compresses, wraps, and pads). Prescription-based cold pain therapy products are categorized into motorized and non-motorized devices. The OTC segment is expected to account for the largest market share in 2016, whereas the prescription-based segment is expected to grow at the highest CAGR, mainly due to the rising incidence of sports-related injuries, continuously increasing aging population, increased incidences of deep vein thrombosis (DVT), and the increasing number of surgeries.
This report covers five major applications musculoskeletal disorders, sport medicine, post-operative, post-trauma, and physical therapy. The musculoskeletal disorders segment is expected to account for the largest share of the global cold pain therapy market in 2016 and grow at the highest CAGR during the study period. This can be attributed to the increasing number of individuals suffering from arthritis, osteoarthritis, back pain, joint pain; rising proportion of geriatric population; aggressive marketing strategies employed by market players; and increasing preference for self-care in the management of musculoskeletal pain.